Tag:
Leo Pharma
Latest Headlines
Latest Headlines
LEO Pharma slapped with sales-rep overtime suit
The sales-rep overtime fight is spreading. Four LEO Pharma salespeople have filed a putative class action, alleging they're owed overtime under U.S. wage-and-hour laws. The reps accuse LEO of...
Novo leads revolt against Greek price cuts
Novo Nordisk ( NYSE: NVO ) doesn't like the Greek price cuts. So, instead of discounting its medicines by 25 percent as ordered, it's keeping prices the same on its newest insulin products, forcing
Warner Chilcott returns rights to Leo Pharma for $1B
Leo Pharma will reacquire the licensing rights to its topical psoriasis treatments from Warner Chilcott for about $1 billion, the two drugmakers announced today. The deal, which is expected to be
LEO snags Peplin, lesion therapy in $287M buyout
Looking to boost its pipeline for dermatology products, Denmark's LEO Pharma has agreed to buy out Peplin for $287.5 million. The acquisition values Peplin at $16.99 a share and LEO will also extend
